Arvind Kumar Patel | Pharmacology | Best Researcher Award

Posted on by sciencefather

Dr. Arvind Kumar Patel | Pharmacology | Best Researcher Award

Narayan Institute of Pharmacy, Gopal Narayan Singh University | Bihar, India

Dr. Arvind Kumar Patel is a dedicated academician and researcher in the field of Pharmacology. With a strong commitment to education and research, he has made significant contributions to the pharmaceutical sciences. His expertise lies in pharmacological studies, toxicology, and herbal medicine research, aiming to enhance therapeutic approaches for various ailments. His passion for teaching and research continues to inspire students and professionals alike.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  1. Extensive Research Contributions:
    • Published multiple research and review papers in reputed journals, including Scopus and Web of Science indexed journals.
    • Focused research on pharmacology, particularly on allergic conjunctivitis, toxicology, and phytopharmaceuticals, showcasing expertise in niche areas of pharmacology.
  2. Academic and Professional Excellence:
    • Earned a Ph.D. in Pharmacology with a robust academic background.
    • Currently serving as an Assistant Professor, contributing to the field through teaching and mentoring.
    • Experience in multiple institutions, enriching his teaching and research acumen.
  3. Innovative Research and Publications:
    • Contributed book chapters and authored a book on Pharmacology aligned with the PCI syllabus.
    • Presented research findings at various international and national conferences, demonstrating active participation in scientific discussions.
  4. Technical Proficiency:
    • Skilled in pharmacological screening, drug formulation processes, and animal handling.
    • Well-versed in research methodologies, experimental design, and analytical techniques.
  5. Awards and Recognitions:
    • Received awards such as Best Student of the Year and 1st prize in poster presentations, showcasing his dedication and competence.
    • Honored with titles such as “Mr. Perfect,” reflecting his well-rounded personality.

Education 🎓

Dr. Patel pursued his Ph.D. in Pharmacy from IFTM University, Moradabad, India, in 2023. He completed his M. Pharm in Pharmacology from the same university in 2017, securing an impressive 83.50%. His foundational education in pharmacy was obtained from Ashoka Institute of Technology & Management, Varanasi, where he earned his B. Pharm degree in 2015. His academic journey was rooted in a strong foundation laid at Mahabodhi Inter College, Varanasi.

Experience 🌟

Dr. Patel is currently serving as an Assistant Professor at Narayan Institute of Pharmacy, Gopal Narayan Singh University, Bihar, since June 2024. Previously, he gained valuable teaching experience at Baba Baijnath College of Pharmacy, Azamgarh, for two years and at Apex Institute of Pharmacy, Mirzapur, for five years. His vast teaching experience has equipped him with deep insights into pharmaceutical sciences and student mentorship.

Research Interest On Pharmacology 📚

His research interests revolve around pharmacological screening, herbal medicine, and drug toxicity studies. His notable research includes investigations into the anti-allergic conjunctivitis effects of medicinal plants and toxicity studies of plant extracts. His work aims to bridge the gap between traditional medicine and modern pharmacological advancements.

Awards & Achievements 🏆

Dr. Patel has received multiple accolades for his contributions to pharmaceutical sciences, including:

  • 1st Prize in Poster Presentation at ABHYUDAY (2014), Annual Fest of Ashoka Institute of Technology & Management.
  • Best Student of the Year (2015) at Ashoka Institute of Technology & Management.
  • Honored as Mr. Perfect (2015) in his farewell event.

Publications 📝

Dr. Patel has authored several research papers, review articles, and book chapters in reputed journals and publishing platforms. Some of his notable publications include:

  • Title: Thermodynamic life cycle assessment of humans with considering food habits and energy intake
    Authors: AK Patel, SPS Rajput
    Year: 2020
    Citations: 10

  • Title: Effects of nanofluid flow in micro channel heat sink for forced convection cooling of electronics device: a numerical simulation
    Authors: AK Patel, S Bhuvad, SPS Rajput
    Year: 2019
    Citations: 10

  • Title: Design and heat transfer performance analysis of mini-channel heat sink with water, EG and EG20 based nanofluids-computational approach
    Authors: AK Patel, SPS Rajput, R Kumar, A Sharma, AP Singh, MK Sharma, …
    Year: 2022
    Citations: 9

  • Title: Numerical analysis of micro-channel heat sink using ethylene glycol based nanofluid in case of electronics cooling
    Authors: SS Bhuvad, AK Patel, SPS Rajput
    Year: 2020
    Citations: 3

  • Title: Parametric Analysis of Energy and Exergy of the human body in Indian conditions
    Authors: SP Arvind Kumar Patel
    Year: 2020
    Citations: 2

  • Title: A review on human biological material-types, uses, storage and disposal
    Authors: AK Patel, SPS Rajput
    Year: 2019
    Citations: 2

  • Title: CFD Analysis for Heat Transfer Enhancement of Microchannels Heat Sink Using Nanofluid Flow in Case of Electronics Device
    Authors: SS Bhuvad, AK Patel, SPS Rajput
    Year: 2020
    Citations: 1

  • Title: Entropy production and Human life cycle assessment for Indians with considering protein, fat, and carbohydrate
    Authors: SP Arvind Kumar Patel
    Year: 2020

  • Title: Simulation of Natural Draft wet cooling tower with variation of Air inlet height through Computational Fluid Dynamics
    Authors: AS Arvind Kumar Patel
    Year: 2013

Conclusion 📝

Dr. Arvind Kumar Patel is a committed educator, researcher, and pharmacologist with a deep passion for advancing the field of pharmaceutical sciences. His contributions to research and academia continue to benefit students and professionals, furthering innovations in herbal pharmacology and drug toxicity studies. Through his dedication and expertise, he aspires to make a lasting impact in the domain of pharmacy and healthcare.

Jinhui Ma | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Jinhui Ma | Medicine | Best Researcher Award

Associate doctor | China-Japan Friendship Hospital | China

A dedicated orthopedic specialist at China-Japan Friendship Hospital, Department of Bone and Joint Surgery, serving as an Associate Chief Physician, with profound expertise in diagnosing and treating complex bone and joint conditions. His commitment to advancing orthopedic care is exemplified by his contributions to clinical research, academic publications, and medical education.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Extensive Clinical Expertise: Specializes in diagnosing and treating complex bone and joint diseases, with a focus on early treatment of osteonecrosis of the femoral head and hip preservation techniques.
  • Research Excellence: Has led notable research projects, including one funded by the Beijing Natural Science Youth Fund and another by the China-Japan Friendship Hospital, while contributing to three National Natural Science Foundation projects.
  • Publication Record: As first and co-first author, has published 17 SCI articles and nearly 8 core journal articles, showcasing a strong contribution to the academic community.
  • Academic Contributions: Participated in compiling three orthopedic books and contributed to the development of two utility model patents.
  • Recognition and Awards: Recipient of the “Outstanding Scientific Research Award” and “Excellent Graduate” award from Peking University, reflecting research excellence.
  • Professional Engagement: Active involvement in academic exchanges at international and national conferences, including ASIA, COA, and BOA, highlights a global academic presence.
  • Leadership Roles: Holds multiple editorial board positions and leadership roles in prestigious medical societies, further emphasizing professional recognition.

Education 🎓

He earned his Doctorate in Clinical Medicine from the Peking University Health Science Center, where he was recognized as an “Excellent Graduate” and received the “Outstanding Scientific Research Award.”

Experience 💼

He honed his skills at Queen Mary Hospital of the University of Hong Kong, specializing in joint replacement technology. He has extensive experience in early treatment of osteonecrosis of the femoral head, hip preservation, osteoarthritis, rheumatoid arthritis, hip dysplasia, motor system injuries, total knee and hip replacements, as well as knee and shoulder arthroscopy.

Research Interests On Medicine 🔬

His research focuses on the diagnosis and treatment of osteonecrosis of the femoral head, hip preservation techniques, advancements in joint replacement, and improving outcomes in complex bone and joint diseases.

Awards 🏆

  • Excellent Graduate of Peking University
  • Outstanding Scientific Research Award, Peking University
  • First Prize, Battle of 100 Groups, China Association for Health Promotion and Education
  • Third Prize, Chinese Orthopedic Good Doctor Reading Contest, Chinese Journal of Bone and Joint Surgery
  • Excellent Prize, Speech Contest (Beijing), Editorial Committee of the Chinese version of JBJS

Publications 📖

He has authored 17 SCI articles and nearly 8 papers in core journals as the first or co-first author. Additionally, he participated in the compilation of three orthopedic books, such as “Osteonecrosis and Strategies for Diagnosis and Treatment of Joint Surgery.”

  • Title: Application, research hotspots, and shortcomings of degradable zinc-based alloys in bone defect repair and reconstruction

    • Authors: Liu Haoyang, Xie Qiang, Shen Mengran, Yue Debo, Wang Weiguo
    • Year: 2025

  • Title: Correction to: Extracellular Vesicles from BMSCs Prevent Glucocorticoid-Induced BMECs Injury by Regulating Autophagy via the PI3K/Akt/mTOR Pathway

    • Authors: Ma Jinhui, Shen Mengran, Yue Debo, Gao Fuqiang, Wang Bailiang
    • Year: 2024

  • Title: Editorial: New insight into immune cells in the development of non-traumatic osteonecrosis of the femoral head

    • Authors: Zhou Yu, Ma Jinhui, Zhang Qingyu, Wang Bailiang
    • Year: 2024

  • Title: Interleukin-33-mediated bone immunity

    • Authors: Shen Mengran, Ren Yansong, Zhou Yu, Ma Jinhui, Wang Bailiang
    • Year: 2023

Professional Contributions

He has led one Beijing Natural Science Youth Fund project, one China-Japan Friendship Hospital project, and contributed to three National Natural Science Foundation projects. His work also includes developing two utility model patents. Academically, he has presented at prestigious conferences like the Asian Association of Joint Replacement (ASIA), National Association of Orthopaedics (COA), and Beijing Orthopedic Association (BOA).

Professional Memberships 🔒

He serves as Secretary General of the Orthopedic Group of the Professional Committee of Translational Medicine of the Chinese Society of Microcirculation and holds memberships in:

  • Young and Middle-aged Editorial Committees of the Chinese Journal of Trauma, Chinese Journal of Reconstructive Surgery, Chinese Journal of Tissue Engineering, and Traditional Chinese Medicine Bone Setting.
  • Youth Working Committee of the Professional Committee of Translational Medicine, Chinese Society of Microcirculation.
  • Expert Committee on Bone Circulation and Osteonecrosis, Professional Committee of Shock Wave Medicine, Chinese Research Hospital Association.

Conclusion 🌟

His remarkable contributions to orthopedics, spanning clinical practice, research, and academic engagement, have made a lasting impact on the field. His passion for advancing orthopedic care and educating future generations continues to shape the future of bone and joint surgery.

Xiaoling Ma | Medicine | Best Researcher Award

Posted on by sciencefather

Prof. Xiaoling Ma | Medicine | Best Researcher Award

Chief physician | The first hospital of Lanzhou university | China

Dr. Xiaoling Ma is a distinguished Chief Physician and Associate Professor, currently serving as the Director of the Reproductive Medicine Center at The First Hospital of Lanzhou University. With over two decades of experience in reproductive medicine, she has made significant contributions to the advancement of assisted reproductive technology (ART). Dr. Ma is a nationally recognized expert in ART management and holds key positions in several prestigious reproductive medicine organizations in China. Her expertise encompasses reproductive endocrinology, fertility preservation, and genetic screening technologies.

Profile👤

Scopus

Strengths for the Awards✨

✅ Extensive Research Contributions: Xiaoling Ma has published over 30 articles in SCI and core Chinese journals, indicating a strong research output. Recent publications in Biomedicine & Pharmacotherapy, Reproductive Sciences, and BMC Medical Genomics highlight her contributions to reproductive medicine.

✅ Leading Research and Innovation: She has led multiple national and provincial research projects, including studies on reproductive genetics, fertility preservation, and endometriosis mechanisms.

✅ Academic and Professional Influence: As a chief physician, associate professor, and director of the Reproductive Medicine Center, her influence extends to clinical practice, academic mentorship, and policy advisory roles.

✅ Editorial and Professional Leadership: Serving as the Chinese editor for Human Reproduction Update and holding key roles in reproductive medicine associations in China demonstrate her leadership in the field.

🎓 Education

Dr. Xiaoling Ma obtained her Master’s degree in Medicine from a renowned Chinese institution. She has pursued extensive postgraduate training and specialized programs in reproductive medicine, refining her knowledge in assisted reproductive technology, reproductive endocrinology, and genetic screening. Her continuous pursuit of academic excellence has positioned her as a leading educator and mentor in reproductive healthcare.

💼 Experience

With a distinguished career spanning over 20 years, Dr. Ma has been instrumental in pioneering and implementing ART techniques. She has successfully led numerous national and provincial medical projects in China, focusing on fertility evaluation, genetic screening, and reproductive health. In addition to her clinical practice, she plays a pivotal role in policy-making and regulatory aspects of reproductive medicine, ensuring the ethical implementation of ART procedures. As an educator, she has trained and mentored countless physicians, enhancing the field of reproductive medicine across China.

🔬 Research Interests On Medicine

Dr. Ma’s research is dedicated to three-level prevention and control of birth defects, fertility preservation in cancer patients, and the application of genetic screening in reproductive health. She explores the mechanisms behind endometriosis, recurrent pregnancy loss, and infertility, aiming to develop innovative treatment protocols. Her contributions to preimplantation genetic testing (PGT) and reproductive immunology have significantly influenced reproductive healthcare in China and beyond.

🏆 Awards and Recognitions

Dr. Ma has been recognized for her outstanding contributions to reproductive medicine and has received multiple accolades at the national and provincial levels. She is an esteemed member of leading reproductive medicine societies and has played a crucial role in shaping policies related to ART in China. She has also been actively involved in national academic conferences, furthering research and clinical advancements in reproductive health.

📚 Publications

Dr. Ma has published over 30 research articles in SCI-indexed and Chinese core journals. Below are some of her notable publications:

  1. Guan, D., Sun, W., Gao, M., Chen, Z., & Ma, X. (2024). Immunologic insights in recurrent spontaneous abortion: Molecular mechanisms and therapeutic interventions. Biomedicine & Pharmacotherapy, 177, p.117082. [Cited by articles]
  2. Liu, L., Liu, Y., Tian, Y., Cao, Y., Wang, T., Mi, S., Yang, R., Liu, S., Ma, X., & Wang, J. (2024). Identification of differentially expressed mRNAs and lncRNAs contributes to elucidation of underlying pathogenesis and therapeutic strategy of recurrent implantation failure. Reproductive Sciences, pp.1-14. [Cited by articles]
  3. Wang, T., Zhang, L., Gao, W., Liu, Y., Yue, F., Ma, X., & Liu, L. (2024). Transcriptome-wide N6-methyladenosine modification profiling of long non-coding RNAs in patients with recurrent implantation failure. BMC Medical Genomics, 17(1), p.251. [Cited by articles]
  4. Guan, D., Zhao, L., Shi, X., Ma, X., & Chen, Z. (2023). Copper in cancer: from pathogenesis to therapy. Biomedicine & Pharmacotherapy, 163, p.114791. [Cited by articles]

🔚 Conclusion

Dr. Xiaoling Ma is a pioneering figure in reproductive medicine, dedicated to advancing ART and genetic screening technologies. Her extensive clinical expertise, innovative research, and leadership in reproductive medicine make her a highly respected figure in her field. Through her work, she continues to impact countless lives, improving fertility treatments and reproductive healthcare policies. Her commitment to teaching, research, and patient care ensures a lasting legacy in reproductive medicine.

Youngji Jo | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Youngji Jo | Medicine | Best Researcher Award

Assistant Professor | UConn Health | United States

Dr. Youngji Jo is an esteemed researcher and academic with a profound background in public health sciences, epidemiology, and health systems modeling. She currently serves as an Assistant Professor in the Department of Public Health Science at the University of Connecticut (UConn Health), USA. With a wealth of experience in infectious disease modeling, health economics, and digital health, Dr. Jo has made significant contributions to global health research, particularly in tuberculosis (TB), HIV, and COVID-19 studies. Her interdisciplinary expertise bridges epidemiology, policy evaluation, and data-driven decision-making.

Profile👤

ORCID

Scopus

Google Scholar

Strengths for the Awards✨

✅ Outstanding Research Contributions: Dr. Youngji Jo has an extensive research portfolio, with expertise in epidemiology, infectious disease modeling, digital health, and public health interventions. She has made significant contributions to tuberculosis (TB) and HIV/AIDS research, as well as COVID-19 modeling, demonstrating her impact on global health policy and disease control.

✅ Strong Funding and Grant Record: She has secured multiple prestigious grants, including from the NIH (F32 Fellowship), Bill & Melinda Gates Foundation, and Korea Disease Control and Prevention Agency. Her ability to attract competitive funding highlights the recognition of her work in the scientific community.

✅ Interdisciplinary and Global Research Impact: Her work spans multiple countries, including the U.S., South Korea, India, Bangladesh, and Nigeria. She has collaborated with top institutions such as Johns Hopkins University, Boston Medical Center, Korea University, and the WHO, indicating a strong global research network.

✅ Applied and Policy-Relevant Research: Her projects focus on real-world impact, such as cost-effectiveness of public health interventions, mathematical modeling of infectious diseases, and policy development for pandemics. This makes her research highly relevant to public health decision-making.

✅ Recognition and Awards: She has received several competitive scholarships and fellowships, such as the NIH Fellowship, WHO-JHU Global mHealth Initiative Scholarship, and conference awards from the International AIDS Society and CROI, reflecting her academic excellence.

Education 🎓

Dr. Jo earned her Ph.D. in Health Systems from the International Health Department at Johns Hopkins Bloomberg School of Public Health, USA. Her doctoral dissertation focused on the cost-effectiveness and scalability of an mHealth intervention to improve pregnancy surveillance in rural Bangladesh. She further enhanced her expertise with post-doctoral fellowships at Boston Medical Center and Johns Hopkins Bloomberg School of Public Health, specializing in infectious disease modeling and health systems research. She holds an M.A. in International Economics & International Relations from Johns Hopkins School of Advanced International Studies (SAIS) and a B.E. in Electrical Engineering from Seoul National University, South Korea.

Experience 💼

Dr. Jo’s extensive research career includes roles as a Post-Doctoral Fellow at Boston University, where she investigated the intersection of HIV and TB care delivery. She has served as a Research Scientist at the Bill & Melinda Gates Foundation, developing agent-based stochastic TB models. Additionally, she has collaborated with global institutions such as the Korea Disease Control and Prevention Agency, RIGHT Foundation, and WHO, contributing to the development of health technologies, pandemic policy evaluations, and mathematical modeling for infectious diseases.

Research Interests On Medicine 📝

Dr. Jo’s research spans multiple critical areas of public health, including:

  • Infectious disease modeling (TB, HIV, COVID-19)
  • Health economics and cost-effectiveness analysis
  • Digital health interventions and mHealth solutions
  • Global health policy evaluation
  • Big data and artificial intelligence applications in epidemiology

Awards & Honors 🏆

Dr. Jo has received numerous accolades for her contributions to public health research, including:

  • Pre-K Junior Faculty Career Development Award (2022-Present)
  • NIH F32 Individual Fellowship Grant (2020-2022)
  • International AIDS Society Conference Scholarship (2021)
  • Gordis Teaching Fellowship at Johns Hopkins University (2014)
  • WHO-JHU Global mHealth Initiative Scholarship (2012)
  • Japan Student Services Organization (JASSO) Government Scholarship (2005-2006)

Publications 📚

Dr. Jo has published extensively in high-impact journals. Some of her recent publications include:

  • Integrated multi‐month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost‐effectiveness

    • Year: 2025
    • Authors: Youngji Jo, Sydney Rosen, Brooke E. Nichols, Lise Jamieson, Nkgomeleng Lekodeba, Robert Horsburgh, Jr.

  • Nationwide Target Trial Emulation Evaluating the Clinical Effectiveness of Oral Antivirals for COVID-19 in Korea

    • Year: 2024
    • Authors: Kyungmin Huh, Youngji Jo, Gi Hwan Bae, Hyejin Joo, Munkhzul Radnaabaatar, Hyungmin Lee, Jungyeon Kim, Dong-Hwi Kim, Min-Gyu Yoo, Il Uk Jo et al.

  • Antenatal care in rural Bangladesh: current state of costs, content and recommendations for effective service delivery

    • Authors: Y Jo, K Alland, H Ali, S Mehra, AE LeFevre, S Pak, S Shaikh, P Christian, …
    • Year: 2019
    • Citations: 62

  • Using the lives saved tool (LiST) to model mHealth impact on neonatal survival in resource-limited settings

    • Authors: Y Jo, AB Labrique, AE Lefevre, G Mehl, T Pfaff, N Walker, IK Friberg
    • Year: 2014
    • Citations: 59

  • Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

    • Authors: Y Jo, L Jamieson, I Edoka, L Long, S Silal, JRC Pulliam, H Moultrie, …
    • Year: 2021
    • Citations: 57

  • Drinking and driving in Vietnam: public knowledge, attitudes, and practices

    • Authors: NT Tran, AM Bachani, VC Pham, JC Lunnen, Y Jo, J Passmore, …
    • Year: 2012
    • Citations: 49

  • Model-based cost-effectiveness of state-level latent tuberculosis interventions in California, Florida, New York, and Texas

    • Authors: Y Jo, S Shrestha, I Gomes, S Marks, A Hill, G Asay, D Dowdy
    • Year: 2021
    • Citations: 37

  • Forecasting the value for money of mobile maternal health information messages on improving utilization of maternal and child health services in Gauteng, South Africa: cost …

    • Authors: A LeFevre, MA Cabrera-Escobar, D Mohan, J Eriksen, D Rogers, …
    • Year: 2018
    • Citations: 26

  • Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea

    • Authors: Y Jo, SB Kim, M Radnaabaatar, K Huh, JH Yoo, KR Peck, H Park, J Jung
    • Year: 2022
    • Citations: 23

  • Costs and cost-effectiveness analyses of mCARE strategies for promoting care seeking of maternal and newborn health services in rural Bangladesh

    • Authors: Y Jo, AE LeFevre, K Healy, N Singh, K Alland, S Mehra, H Ali, S Shaikh, …
    • Year: 2019
    • Citations: 23

Conclusion 🔖

Dr. Youngji Jo is a distinguished academic and researcher whose interdisciplinary expertise continues to shape the landscape of global public health. Her contributions to infectious disease modeling, health economics, and digital health interventions have significantly advanced our understanding of TB, HIV, and COVID-19. As she continues her research at UConn Health, her work remains at the forefront of data-driven solutions for global health challenges.

Qun Zhao | Medicine | Outstanding Scientist Award

Posted on by sciencefather

Prof. Qun Zhao | Medicine | Outstanding Scientist Award

The Fourth Hospital of Hebei Medical University | China

Qun Zhao is a distinguished medical professional affiliated with the Third Department of Surgery at the Fourth Hospital of Hebei Medical University. With extensive experience in surgical oncology, he has contributed significantly to the advancement of gastric and gastrointestinal cancer treatments. As a committed researcher and clinician, Dr. Zhao is an active member of multiple professional committees, driving innovation and excellence in cancer therapy.

Profile👤

ORCID

Strengths for the Awards

✅ Extensive Leadership in Oncology Research: Qun Zhao holds key positions in multiple national committees related to gastric cancer, gastrointestinal mesenchymal tumors, peritoneal tumors, tumor support therapy, and surgical nutrition. These roles highlight significant contributions to cancer research and treatment.

✅ Institutional and Professional Affiliations: Being part of the Fourth Hospital of Hebei Medical University, a reputed institution, strengthens credibility. His involvement in China’s Anti-Cancer Association further establishes his expertise in the field.

✅ Contributions to Cancer Surgery & Nutrition: Given the focus on gastric and peritoneal tumors, surgical oncology, and nutrition, Qun Zhao’s work aligns with impactful research that directly benefits patients and advances medical science.

✅ Editorial and Research Contributions: While specific journal publications, patents, or citation indices are not provided, editorial appointments and professional memberships suggest recognition by the academic community.

✅ Potential for Industry Impact: If consultancy or industry projects exist (to be detailed), they could indicate translational research, bridging academia with practical medical applications.

Education 🎓

Dr. Qun Zhao completed his medical education and specialized training in surgical oncology at renowned institutions. His academic journey has been marked by a commitment to continuous learning and specialization in gastrointestinal malignancies and surgical techniques.

Experience 🌟

Dr. Zhao holds a prominent position in the medical field, serving in various leadership roles, including the Standing Committee memberships in multiple prestigious oncology and surgical nutrition groups. His expertise extends across peritoneal tumor management, gastric cancer treatment, and gastrointestinal mesenchymal tumors. His clinical acumen and research contributions have had a significant impact on cancer treatment methodologies.

Research Interests On Medicine 🔬

Dr. Zhao’s research focuses on innovative surgical techniques, tumor nutrition, and multimodal cancer treatment strategies. His work aims to improve patient outcomes through targeted therapies and advanced surgical interventions. His ongoing projects include groundbreaking research in peritoneal metastases and gastrointestinal stromal tumors.

Awards 🏆

Dr. Zhao has been recognized for his outstanding contributions to surgical oncology and cancer research. His accolades include awards from national and international oncology societies for his pioneering work in gastric and peritoneal tumors.

Publications 📚

Dr. Zhao has authored numerous peer-reviewed articles in high-impact journals. Some of his key publications include:

  • Pioneering case: Robot-assisted remote radical distal gastrectomy for gastric cancer based on 5G communication technology
    • Authors: Honghai Guo, Yuan Tian, Jia Shi, Peigang Yang, Jiaxuan Yang, Pingan Ding, Xuefeng Zhao, Zhidong Zhang, Qun Zhao
    • Publication Year: 2024
    • DOI: 10.1016/j.isurg.2024.01.004
  • Comment on ‘Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer’ by Xie et al.
    • Authors: Ping’an Ding, Jiaxiang Wu, Haotian Wu, Chenyu Sun, Muzi Meng, Scott Lowe, Yuan Tian, Honghai Guo, Lingjiao Meng, Qun Zhao
    • Publication Year: 2023
    • DOI: 10.1002/jcsm.13298
  • Comment on: ‘Triceps skinfold‐albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study’ by Yin et al.
    • Authors: Ping’an Ding, Haotian Wu, Jiaxiang Wu, Chenyu Sun, Muzi Meng, Peigang Yang, Yang Liu, Lingjiao Meng, Qun Zhao
    • Publication Year: 2023
    • DOI: 10.1002/jcsm.13304
  • Safety and efficacy of carbon nanoparticle suspension injection and indocyanine green tracer-guided lymph node dissection during robotic distal gastrectomy in patients with gastric cancer
    • Authors: Yuan Tian, Yecheng Lin, Honghai Guo, Yiyang Hu, Yong Li, Liqiao Fan, Xuefeng Zhao, Dong Wang, Bibo Tan, Qun Zhao
    • Publication Year: 2022
    • DOI: 10.1007/s00464-021-08630-8
  • Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
    • Authors: Yuan Tian, Qun Zhao, Yong Li, Liqiao Fan, Zhidong Zhang, Xuefeng Zhao, Bibo Tan, Dong Wang, Peigang Yang, Nicola Silvestris
    • Publication Year: 2021
    • DOI: 10.1155/2021/5590626

Conclusion 🥇

Dr. Qun Zhao’s dedication to oncology research and patient care continues to influence the medical community. His innovative approaches in surgery and therapeutic nutrition play a pivotal role in advancing cancer treatment. His contributions, both in research and clinical practice, underscore his commitment to improving healthcare outcomes globally.

Silvia Di Bonaventura | Health Sciences | Young Scientist Award

Posted on by sciencefather

Ms. Silvia Di Bonaventura | Health Sciences | Young Scientist Award

Lecturer-Researcher | Rey Juan Carlos University | Spain

Silvia Di Bonaventura is a passionate researcher, professor, and social entrepreneur with a commitment to advancing scientific innovation. Her journey reflects an insatiable curiosity, strong leadership, and dedication to contributing to transformative projects in health and biomedicine. Fluent in five languages, she combines global perspectives with academic rigor and entrepreneurial vision to address complex challenges in research and healthcare.

Profile:

Strengths for the Awards:

  1. Academic Excellence:
    Silvia’s strong academic foundation includes degrees in Physiotherapy, Invasive Physiotherapy, and an ongoing PhD in Pain Research, coupled with a Master’s in Clinical Research at Harvard University, showcasing her commitment to scientific rigor and innovation.
  2. Research Contributions:
    Silvia has demonstrated significant contributions to pain research, with notable publications on neuromodulation and digital health interventions for chronic pain. Her work combines clinical relevance and innovative methodologies, emphasizing her potential to make lasting impacts in biomedicine.
  3. Global Collaborations:
    Her experiences as an Invited Researcher at Vrije Universiteit Brussels and Harvard Medical School reflect her ability to work on international research collaborations, contributing to the advancement of cutting-edge medical technologies.
  4. Entrepreneurial Leadership:
    As the CEO of Bei (a digital health app for fibromyalgia) and the Founder of PainCorp, Silvia has effectively bridged research with practical healthcare solutions, emphasizing her visionary approach and ability to create real-world impact.
  5. Awards and Recognitions:
    Silvia’s accolades, including the Banco Santander Scholarship, Young Emerging Leader 2022, and the Outstanding Leadership Award, highlight her dedication, leadership, and exceptional achievements in the field.
  6. Multilingual Communication Skills:
    Fluent in five languages, Silvia has the ability to collaborate and communicate effectively across diverse cultures, enhancing her research’s global reach and impact.

🎓Education 

  • Diploma in Computer Science (2009–2014)
    Instituto Técnico Industrial “IIS” – TE
  • Degree in Physiotherapy (2014–2018)
    Universidad Alfonso X El Sabio
  • Master’s Degree in Invasive Physiotherapy (2017–2018)
    Universidad Camilo José Cela
  • Master’s Degree in Clinical Research (2024–2024)
    Harvard University
  • PhD in Pain Research (2021–Present)
    Universidad Rey Juan Carlos

💼Experience 

  • Physiotherapist & Co-Director
    Clínica Gatzambide (2018–2022)
    Led a successful physiotherapy practice focused on personalized patient care.
  • Professor & Researcher
    Rey Juan Carlos University (2021–Present)
    Teaching and conducting groundbreaking research in pain management.
  • Invited Researcher
    Vrije Universiteit Brussels (2023) & Harvard Medical School (2024)
    Advanced research on neuromodulation and pain mechanisms.
  • Entrepreneurial Roles
    • CEO & Founder of Bei (2024–Present): Innovating solutions for fibromyalgia self-management.
    • President of PainCorp (2024–Present): Dedicated to pain research and treatment.
    • Research Fellow at Mit LinQ and Harvard (2024–Present): Driving forward collaborative research initiatives.

🔬Research Interests On Health Sciences

Silvia’s research centers on pain management, clinical research, neuromodulation, and digital health solutions. She is particularly focused on designing innovative interventions for chronic pain conditions such as fibromyalgia, combining scientific rigor with practical applications for patient care.

🏆Awards 

  • Top 15 Graduates in Spain (Physiotherapy Ranking)
  • Banco Santander Scholarship (Best Academic Record)
  • PI in Competitive Funding (Biomedicine Research)
  • Entrepreneurship Babson College Scholarship
  • Nova Talent Member
  • Young Emerging Leader ’22 (Korea World Summit)
  • Outstanding Leadership Award (Harbour Space University)

🥇Achievements & Certifications

  • Recognized as one of the Top 15 Graduates in Spain in Physiotherapy.
  • Awarded Banco Santander Scholarship for academic excellence.
  • Recipient of Babson College Entrepreneurship Scholarship for advancing digital health solutions.
  • Certified in Italian (Native), Spanish (C2), English (C1), French (B1), and Chinese (HSK2).

🌍Final Note

Silvia Di Bonaventura exemplifies a modern researcher blending academic excellence, global collaboration, and entrepreneurship. Through her multifaceted roles, she seeks to bridge the gap between research and real-world impact, paving the way for transformative solutions in healthcare.

Publication Top Note’s

“How Does Conditioned Pain Modulation Influence Motor Imagery Processes in Women with Fibromyalgia Syndrome? A Cross-Sectional Study Secondary Analysis”

  • Authors: Víctor Riquelme-Aguado, Silvia Di-Bonaventura, María Elena González-Álvarez, Alazne Zabarte-Del Campo, Josué Fernández-Carnero, Antonio Gil-Crujera, Francisco Gómez-Esquer, Jorge Hugo Villafañe
  • Journal: Journal of Clinical Medicine
  • Year: 2024

“The Link between Endogenous Pain Modulation Changes and Clinical Improvement in Fibromyalgia Syndrome: A Meta-Regression Analysis”

  • Authors: Kevin Pacheco-Barrios, Rafaela Machado Filardi, Luis Fernando González-González, Nayeon Park, Fernanda Queiroz Petrus, Alba Navarro-Flores, Silvia Di-Bonaventura, Luana Gola Alves, Fernanda Queiroz, Felipe Fregni
  • Journal: Biomedicines
  • Year: 2024

“Perceived Benefits and Limitations of a Psychoeducation Program for Patients with Fibromyalgia: An Interpretative Phenomenological Analysis”

  • Authors: Silvia Di-Bonaventura, Raúl Ferrer-Peña, Joaquín Pardo-Montero, Josué Fernández-Carnero, Roy La Touche
  • Journal: Frontiers in Psychology
  • Year: 2024

“Effectiveness of Biobehavioral Therapeutic Education in Chronic Low Back Pain Intensity and Disability: A Systematic Review”

  • Authors: David Ruíz-del Río, Roy La Touche, Gwendoline Giolito, Silvia Di-Bonaventura, Mónica Grande-Alonso, Álvaro Reina Varona
  • Journal: Journal of MOVE and Therapeutic Science
  • Year: 2024

“Can a Specific Biobehavioral-Based Therapeutic Education Program Lead to Changes in Pain Perception and Brain Plasticity Biomarkers in Chronic Pain Patients? A Study Protocol for a Randomized Clinical Trial”

  • Authors: Silvia Di Bonaventura, Stephen D. Ginsberg, Josué Fernández Carnero, Raúl Ferrer-Peña
  • Journal: PLOS ONE
  • Year: 2024

“Effect of Different Physical Therapy Interventions on Brain-Derived Neurotrophic Factor Levels in Chronic Musculoskeletal Pain Patients: A Systematic Review”

  • Authors: Silvia Di-Bonaventura, Josué Fernández-Carnero, Luis Matesanz-García, Alberto Arribas-Romano, Andrea Polli, Raúl Ferrer-Peña
  • Journal: Life
  • Year: 2023